Quantitative identification of magnetic resonance imaging features of prostate cancer response following laser ablation and radical prostatectomy

Abstract. Laser interstitial thermotherapy (LITT) is a relatively new focal therapy technique for the ablation of localized prostate cancer. In this study, for the first time, we are integrating ex vivo pathology and magnetic resonance imaging (MRI) to assess the imaging characteristics of prostate cancer and treatment changes following LITT. Via a unique clinical trial, which gave us the availability of ex vivo histology and pre- and post-LITT MRIs, (1) we investigated the imaging characteristics of treatment effects and residual disease, and (2) evaluated treatment-induced feature changes in the ablated area relative to the residual disease. First, a pathologist annotated the ablated area and the residual disease on the ex vivo histology. Subsequently, we transferred the annotations to the post-LITT MRI using a semi-automatic elastic registration. The pre- and post-LITT MRIs were registered and features were extracted. A scoring metric based on the change in median pre- and post-LITT feature values was introduced, which allowed us to identify the most treatment responsive features. Our results show that (1) image characteristics for treatment effects and residual disease are different, and (2) the change of feature values between pre- and post-LITT MRIs can be a quantitative biomarker for treatment response. Finally, using feature change improved discrimination between the residual disease and treatment effects.

[1]  M. Zelefsky.  Use of MRI and spectroscopy in evaluation of external beam radiotherapy for prostate cancer , 2005 .

[2]  Anant Madabhushi,et al.  Prostatome: a combined anatomical and disease based MRI atlas of the prostate. , 2014, Medical physics.

[3]  H. Huisman,et al.  Accurate estimation of pharmacokinetic contrast‐enhanced dynamic MRI parameters of the prostate , 2001, Journal of magnetic resonance imaging : JMRI.

[4]  Nico Karssemeijer,et al.  A Pattern Recognition Approach to Zonal Segmentation of the Prostate on MRI , 2012, MICCAI.

[5]  Josephine Hegarty,et al.  Radical prostatectomy versus watchful waiting for prostate cancer. , 2010, The Cochrane database of systematic reviews.

[6]  W. R. Lees,et al.  Dynamic magnetic resonance control of interstitial laser photocoagulation therapy of colorectal hepatic metastases , 1994, The Lancet.

[7]  R. Lenkinski,et al.  Central gland and peripheral zone prostate tumors have significantly different quantitative imaging signatures on 3 tesla endorectal, in vivo T2‐weighted MR imagery , 2012, Journal of magnetic resonance imaging : JMRI.

[8]  Nico Karssemeijer,et al.  Automated computer-aided detection of prostate cancer in MR images: from a whole-organ to a zone-based approach , 2012, Medical Imaging.

[9]  Qiang Li,et al.  Selective enhancement filters for nodules, vessels, and airway walls in two- and three-dimensional CT scans. , 2003, Medical physics.

[10]  R. Lenkinski,et al.  Elastic registration of multimodal prostate MRI and histology via multiattribute combined mutual information. , 2011, Medical physics.

[11]  Anant Madabhushi,et al.  Quantitative evaluation of treatment related changes on multi-parametric MRI after laser interstitial thermal therapy of prostate cancer , 2013, Medical Imaging.

[12]  A. Fenster,et al.  Registration of prostate histology images to ex vivo MR images via strand‐shaped fiducials , 2012, Journal of magnetic resonance imaging : JMRI.

[13]  Andrew B Rosenkrantz,et al.  Role of MRI in minimally invasive focal ablative therapy for prostate cancer. , 2011, AJR. American journal of roentgenology.

[14]  C. Kim,et al.  Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T. , 2010, AJR. American journal of roentgenology.

[15]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[16]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[17]  D. Shen,et al.  Registering histological and MR images of prostate for image-based cancer detection. , 2007, Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention.

[18]  M. Schouten,et al.  ESUR prostate MR guidelines. Author reply. , 2013, European radiology.

[19]  Max A. Viergever,et al.  elastix: A Toolbox for Intensity-Based Medical Image Registration , 2010, IEEE Transactions on Medical Imaging.

[20]  Geoffrey McLennan,et al.  Establishing a normative atlas of the human lung: intersubject warping and registration of volumetric CT images. , 2003, Academic radiology.

[21]  N Karssemeijer,et al.  Automatic computer-aided detection of prostate cancer based on multiparametric magnetic resonance image analysis , 2012, Physics in medicine and biology.

[22]  Kazuro Sugimura,et al.  Prostate cancer detection with 3 T MRI: Comparison of diffusion‐weighted imaging and dynamic contrast‐enhanced MRI in combination with T2‐weighted imaging , 2010, Journal of magnetic resonance imaging : JMRI.

[23]  Anant Madabhushi,et al.  Multi-kernel graph embedding for detection, Gleason grading of prostate cancer via MRI/MRS , 2013, Medical Image Anal..

[24]  T. H. van der Kwast,et al.  Focal laser ablation for prostate cancer followed by radical prostatectomy: validation of focal therapy and imaging accuracy. , 2010, European urology.

[25]  Hashim Uddin Ahmed,et al.  Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? , 2012, The Lancet. Oncology.

[26]  Baris Turkbey,et al.  Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. , 2012, Urology.

[27]  Aytekin Oto,et al.  MR imaging-guided focal laser ablation for prostate cancer: phase I trial. , 2013, Radiology.